PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 88 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,787,207 | -10.4% | 268,776 | +23.8% | 0.00% | 0.0% |
| Q2 2023 | $3,110,103 | +104.6% | 217,186 | +2.0% | 0.00% | – |
| Q1 2023 | $1,520,114 | -35.8% | 212,901 | +0.9% | 0.00% | – |
| Q4 2022 | $2,367,970 | +11.5% | 211,049 | +10.1% | 0.00% | – |
| Q3 2022 | $2,124,000 | +32.6% | 191,709 | +1.0% | 0.00% | – |
| Q2 2022 | $1,602,000 | -34.2% | 189,888 | +6.2% | 0.00% | – |
| Q1 2022 | $2,433,000 | -34.2% | 178,810 | -4.8% | 0.00% | -100.0% |
| Q4 2021 | $3,696,000 | -38.1% | 187,905 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $5,973,000 | -9.4% | 186,076 | -4.5% | 0.00% | 0.0% |
| Q2 2021 | $6,596,000 | +33.2% | 194,876 | +47.8% | 0.00% | 0.0% |
| Q1 2021 | $4,952,000 | +13.5% | 131,856 | +0.4% | 0.00% | 0.0% |
| Q4 2020 | $4,363,000 | -10.2% | 131,321 | -0.9% | 0.00% | 0.0% |
| Q3 2020 | $4,857,000 | +2.9% | 132,448 | -7.7% | 0.00% | 0.0% |
| Q2 2020 | $4,721,000 | +39.3% | 143,453 | +9.3% | 0.00% | 0.0% |
| Q1 2020 | $3,389,000 | -4.9% | 131,258 | +14.7% | 0.00% | 0.0% |
| Q4 2019 | $3,563,000 | – | 114,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,484,274 | $27,873,554 | 11.71% |
| Frazier Life Sciences Management, L.P. | 8,407,152 | $94,328,245 | 5.86% |
| Abingworth LLP | 1,435,106 | $16,101,889 | 5.25% |
| Opaleye Management Inc. | 417,500 | $4,684,350 | 1.63% |
| 683 Capital Management, LLC | 1,350,000 | $15,147,000 | 1.28% |
| Newtyn Management, LLC | 484,074 | $5,431,310 | 1.12% |
| Penn Mutual Asset Management | 62,802 | $704,638 | 0.79% |
| StepStone Group LP | 422,085 | $4,735,794 | 0.62% |
| MPM BioImpact LLC | 195,942 | $2,198,469 | 0.57% |
| Avidity Partners Management LP | 1,900,000 | $21,318,000 | 0.46% |